Prevalence of smear positivity, hiv co-infection, trend and treatment outcome among tuberculosis patients accessing care at faith alive foundation, Jos, Nigeria

Background: Tuberculosis (TB) in the African sub-region, is still a public health problem, heightened by its synergy with HIV. Sputum smear positivity which is diagnostic indicator often gives a lower prevalence of the disease that may be give a false burden of the disease thus leading to varied treatment outcomes that may add to the vicious cycle of the magnitude of the disease. Thus, the prevalence of sputum positivity and co-infection with HIV; trend and treatment outcomes of TB were assessed. Methods: Secondary data of TB patients from 2012 (commencement of TB care at this centre) 2018 at Faith Alive Foundation Jos, a renowned faith-based hospital with approximately with a large monthly patient turn-out rate. Software SPSS version 18 was used for data analysis. Results: Females adults were more affected; prevalence of sputum positivity/HIV co-infection were 15.1% (14% in adult; 1.1% in children) / 62.0% (57.4% in adults; 4.6% in children) respectively. The 7-year trend spiked in year 2015 and 2017, with an observed downward pattern in 2018 in all the ages. Cure after treatment was 6.3% (5.7% in adults and 0.6% in children). Conclusion: Efforts will need to be put into TB diagnosis considering the low sensitivity of sputum smear microscopy in instituting treatment. TB is still a leading opportunistic infection in persons infected with HIV. Research Article Prevalence of smear positivity, hiv co-infection, trend and treatment outcome among tuberculosis patients accessing care at faith alive foundation, Jos, Nigeria Agbo HA1*, Banwat ME1, Isichei M2 and Isichei Chris3 1Department of Community Medicine, Jos University Teaching Hospital/University of Jos, Nigeria 2Department of Surgery, Jos University Teaching Hospital/University of Jos, Nigeria 3Department of Chemical Pathology, Jos University Teaching Hospital/University of Jos, Nigeria Received: 04 June, 2021 Accepted: 26 June, 2021 Published: 28 June, 2021 *Corresponding author: Agbo HA, Department of Community Medicine, Jos University Teaching Hospital/University of Jos, Nigeria, Tel: 08034521494; E-mail:


Introduction
Tuberculosis (TB) is amongst diseases that have affected mankind from time immemorial, whose causative agents and cure were initially obscured thus contributing signifi cantly to morbidity and mortality [1][2][3]. Compared with diseases caused by a single infectious agent, it is the second biggest cause of mortality globally [4,5]. A third of the world's population has been exposed and being infected with the organism with varying degrees of severity [6]. Globally, TB is currently responsible for more years of healthy life lost (2.5 percent of all disabilityadjusted life years, or DALYs) than any other infectious disease [7], primarily infecting the lungs. The TB may be at the latent or active phase among persons infected [8].
Efforts have been made to curtail TB such as the Bacillus Calmette Guerin (BCG) vaccine administered to babies at birth [9,10]. In addition, the World Health Organization (WHO) designates a day annually to create awareness aimed at minimizing its global burden. Despite all these efforts, TB burden is still a problem in the African sub-region. Now with the advent of Human Immunodefi ciency Virus (HIV) infection, there is a dramatic resurgence of TB with more than 8 million new cases each year worldwide and more than 2 million persons dying from it [11]. The emergence of HIV has made all the battles aimed at reducing these predisposing factors to TB infection fruitless. Mainly because TB is the most common opportunistic infections of persons infected with HIV. Additionally, the sub-Saharan countries have Citation: Agbo  barely curtailed the double burden of diseases imposed by the infectious diseases (diarrhoea disease, measles, etc.) and noninfectious diseases (diabetes, hypertension, obesity, cancers due to epidemiologic transition) then the advent of HIV and some re-emerging diseases, thus creating a triple burden on the health system and a further weakening of the already frail system. The synergy of TB and HIV co-infections poses particular diagnostic and therapeutic challenges e.g. infection with HIV is the most powerful known predisposing risk factor for Mycobacterium tuberculosis infection and progression to active disease, which increases the risk of latent TB reactivation to about 20-folds. Tuberculosis on the other hand is the most common cause of AIDS-related death in persons infected with HIV. Thus, they act in synergy, accelerating the decline of immunological functions and leading to subsequent death if untreated though the mechanisms behind the breakdown of the immune defense of the co-infected individual are not well known [12]. The HIV like many diseases affecting mankind in a pandemic proportion has not spared any age group and has brought a lot of setbacks [13][14][15][16][17], and the Nigerian health system had suffered several infectious disease outbreaks year after year [18,19], which has continuously weakened the system and contributing to the increasing trends of diseases despite numerous health interventions. It is estimated that each day there are about 1,000 new infections of HIV in Nigeria and 2011 WHO report on other health problems in the country has shown that the number of reported cases of malaria is on the increase [20]. In spite of the various reforms to increase the provision of health to the Nigerian people, many still fi nd it extremely diffi cult to afford the high cost of health care Figure 1 [21].
Among the 30 high TB burden countries who accounted for 87% of the new cases; Nigeria is one of them. Ending the TB epidemic by 2030 is among the health targets of the United Nations Sustainable Development Goals (SDGs) [23]. According to the WHO, mortality from TB is seen among HIV-negative people and additionally from HIV-associated TB [24]. More than 95% of TB deaths occurred in low and middle-income countries [23,25]. The two synergetic partners (TB and HIV) pose a threat to a desired healthy population especially in sub-Saharan Africa which provides other enabling factors to these diseases Figure 2.
The World Health Organization estimates that 9 million people a year get sick with TB, with 3 million of these "missed" by health systems [22,27]. The contribution of TB to child mortality is undetermined, particularly in TB endemic areas and a substantial number of children dying from meningitis, presumed sepsis, HIV/AIDS, or severe malnutrition may have had TB as its underlying cause [28], thus, the real burden of childhood TB in Sub-Saharan Africa is not known. A Malawi study found that 12% of all registered TB cases were children less than 15 years of age [9,29]. In the United States, a total of 9,582 cases of TB were reported in 2013, of which 485 (5%) cases were among children less than 15 years of age. In high TB burden settings outside of the United States, children account for an estimated 15-20% of TB cases [29], Children with latent infections become reservoirs for future transmission following disease reactivation in adulthood, thus fueling future epidemics [30].
The study determined the prevalence; trend and treatment outcome of patients who received TB treatment at the health centre.
The study was framed on the Donabedian health care model with a framework for examining health services and evaluating the quality of health care based on organizational structure, process and outcomes [31].

Materials and methods
Secondary data of TB patients seen from 2012 (commencement of TB care at this centre) -2018 at Faith Alive Foundation Jos, a faith-based hospital with approximately 10,000 patients seen monthly were assessed. A minimum sample size of 300 was calculated [32]. N = Z 2 pq/d2; Where N = minimum sample size Z = alpha level corresponding to the 95% confi dence interval = 1.96 P = Proportion of TB cases co-infected with HIV in African countries was 39% = 0.39 [26,33]. q = 1-p d = maximum acceptable error margin = 5% or 0.05

Inclusion criteria
Data of all registered TB patients was assessed.

Ethical consideration
Written consent was sought for and obtained from the Health Research Ethics Committee of Faith Alive Centre, Jos (Appendix I).

Limitation of the study
Treatment outcome is usually infl uenced by factors that may affect the external validity of the data collected.

Discussion
Many problems have been attributed to the spread of TB in the sub-region; such are immune suppressive conditions like HIV/AIDS, malnutrition, overcrowding, non/poor utilization of health facilities, etc. Smear positivity in making a working diagnosis of TB is still of upmost concern; even in HIV negatives, this may be high [34]. The burden of TB was observed more among adults than children with a smear positivity of (14%) in the adults and (1.1%) in the children, similar (14%); [35], lower than that obtained from a pooled meta-analysis with prevalence of sputum smear positive TB of (52%) in adults and (6.8%) in children; [36] whose fi ndings may have being infl uenced by the massive data pooled from 14 countries. Lower prevalence were compared with an Ethiopian study among homeless adults (2.6 %) [37]; (5.4%) [38] in another Ethiopian study (10%) [39] TB infection was higher among the female gender as against the male preponderance from other studies, this may be due to the peculiarities in most Africans where cultural restrictions on nutritious foods may predispose more females to lower immunity with a higher risk of TB than her male counterpart. Polygamy which may fuel the spread of HIV (the synergistic partner of TB) may indirectly account for the female prevalence and the higher TB/HIV co-infection seen in more than half of the adult population. Heterogeneity of smear positivity was recorded from the different study assessed with marked disparity among age groups and gender [39][40][41][42] in    Citation: Agbo [44]. The trend will provide a basis for effective monitoring and supervision, and an indirect audit of the many efforts that is/has been put into reducing the disease in the state through regional and national efforts.
The desired treatment outcome is a complete cure; this wasn't the case in the 7 years under review. TB-HIV co-infected people are facing multifaceted problems like high lost to follow up rates, poor treatment adherence, high TB recurrence rate, and high mortality risk [47]. The observed treatment outcomes with defaults, treatment failures, dead; has re-emphasized the fact that TB/HIV co-infection as seen among the patients had a higher chance of unsuccessful treatment outcome [48], despite the accessibility of the treatment centre and its affordability.

Conclusion
This retrospective review of data over seven years has shown that TB and its synergy with HIV infection is still a public health problem and more awareness will need to be created on case detection and treatment.

Recommendations
TB diagnosis by health workers should not only be placed on sputum smear results due to its low sensitivity.
Programmes aimed at TB control should be inclusive of control of HIV by stakeholders in health due to their synergetic association.